4//SEC Filing
Dumas Jacques 4
Accession 0001209191-18-023582
CIK 0001373707other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:03 PM ET
Size
5.5 KB
Accession
0001209191-18-023582
Insider Transaction Report
Form 4
Dumas Jacques
Chief ScientificOfficer
Transactions
- Award
Restricted Stock Units
2018-04-02+40,000→ 40,000 total→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
- [F2]The restricted stock units vest in two equal installments on each of April 2, 2019 and April 2, 2020.
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeother
Related Parties
1- filerCIK 0001598640
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:03 PM ET
- Size
- 5.5 KB